Skip to content

Collaborate

Three ways to work with us.

Choose the path that fits your organisation. Each one says what we offer, what to bring to a first exchange and what usually comes next.

Biotech and pharma R&D teams

Industry

What we offer

Response and resistance profiles for a candidate molecule
Mechanistic hypotheses and target prioritisation
Population mapping to inform study design

What to bring to a first exchange

The candidate or question, in non-confidential terms
The type of data available (or the cohorts you have in mind)
Your timeline and the decision the analysis should inform

Usually next

A scoping call, then a written pilot proposal with scope, inputs, turnaround, price, acceptance criteria and ownership of results.

Discuss an industry pilot

Academic and translational research teams

Laboratory

What we offer

Joint analysis of your transcriptomic data
Mechanistic follow-up and experimental design
Co-authored methods and results, where agreed

What to bring to a first exchange

Your biological question and models
Existing datasets and their metadata
Funding context (grant, collaboration, service)

Usually next

An exchange between researchers, then a collaboration or service agreement adapted to your institution.

Propose a laboratory collaboration

Clinicians, cohorts and biobanks

Clinical

What we offer

Independent validation on well-characterised cohorts
Clinical framing of research findings
Preparation of future studies, under the applicable rules

What to bring to a first exchange

The cohort or expertise you could contribute
Governance and data access conditions
The clinical questions that matter to you

Usually next

A discussion of scientific interest and feasibility, then the agreements and approvals required before any data are shared.

Propose a clinical collaboration

Current needs

Pilot partners for first B2B projects
Access to well-characterised cohorts with treatment response
Regulatory and quality expertise for future clinical development
Intellectual property advice
Funding for independent validation
Introductions to R&D, clinical and funding networks

Funders and investors

Our budget, scenarios and use of funds are shared in a separate, access-controlled space after a first discussion.

Funder space: request access or sign in

Please do not include patient data or confidential material in a first message.